Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10272230 Systems and methods for treating hydrocephalus

Patent 10272230 was granted and assigned to CereVasc, Inc. on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
CereVasc, Inc.
CereVasc, Inc.
Date Filed
October 28, 2016
Date of Patent
April 30, 2019
Patent Applicant
CereVasc, Inc.
CereVasc, Inc.
Patent Application Number
15745961
Patent Citations
‌
US Patent 10004621 Anchoring guidewire and methods for use
‌
US Patent 10022251 Flow diversion device
Patent Citations Received
‌
US Patent 11951270 Systems and methods for endovascularly accessing a subarachnoid space
0
‌
US Patent 11850390 Systems and methods for minimally invasive drug delivery to a subarachnoid space
0
‌
US Patent 12090291 Endovascular cerebrospinal fluid shunt
0
‌
US Patent 12011557 Methods and systems for draining cerebrospinal fluid into the venous system
0
‌
US Patent 10758718 Systems and methods for endovascularly accessing a subarachnoid space
‌
US Patent 10765846 Methods and systems for draining cerebrospinal fluid into the venous system
‌
US Patent 11013900 Systems and methods for minimally invasive drug delivery to a subarachnoid space
‌
US Patent 11278708 Endovascular cerebrospinal fluid shunt
‌
US Patent 11690739 Implantable device for treatment of hydrocephalus
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10272230
Patent Primary Examiner
‌
Philip R Wiest

Find more entities like US Patent 10272230 Systems and methods for treating hydrocephalus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.